Eugenia Leeds
Head of Investor Relations
Replay available
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2025 Earnings Call
Recordati Industria Chimica e Farmaceutica S.p.A. (OTC: RCDTF) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rob Cormans
Chief Executive Officer
Luigi Licorte
Chief Financial Officer
Scott Pescatore
Executive Vice President, Rare Diseases
Sophia Glass
Analyst, G.P. Morgan
Isako Brambilla
Analyst, Mediobanca
Charles Spitman King
Analyst, Barclays
Neil Alexander
Analyst, Deutsche Bank
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Recordati S.p.a..
Replay transcript excerpt
WEBVTT 00:00:00.605 -- 00:00:04.092 Good afternoon. This is the Card School Conference Operator. 00:00:04.092 -- 00:00:10.083 Welcome and thank you for joining the Recordati 9 Month 2025 Results Conference Call. 00:00:10.083 -- 00:00:13.569 As a reminder, all participants are in listen-only mode. 00:00:13.569 -- 00:00:17.954 After the presentation, there will be an opportunity to ask questions. 00:00:18.138 -- 00:00:22.106 If anyone needs assistance during the conference call, they may signal an operator by 00:00:22.106 -- 00:00:27.114 pressing star and zero on the test. At this time, I would like to turn the conference 00:00:27.114 -- 00:00:32.370 over to Mrs. Eugenia Leeds of Recordati Investment Relation. 00:00:32.370 -- 00:00:34.422 Please go ahead, madam. 00:00:34.422 -- 00:00:39.269 Thank you and good afternoon, everyone. I'm pleased to be here today with Rob Cormans, 00:00:39.269 -- 00:00:44.336 our CEO, and Luigi Licorte, our CFO, who will present results for the 00:00:44.336 -- 00:00:49.503 first nine months of 2025. Then Scott Pescatore, Executive Vice 00:00:49.503 -- 00:00:55.651 President of Rare Diseases, will provide further insight into the exciting Estreza opportunity. 00:00:55.651 -- 00:01:01.182 Also joining for the Q&A session will be Alberto Martinez, Executive Vice President 00:01:01.182 -- 00:01:06.291 of Specialty and Primary Care, and Milan Draskovic, Executive Vice President of 00:01:06.291 -- 00:01:11.802 R&D. As always, the presentation is available in the Investor section 00:01:11.802 -- 00:01:15.909 of our website. It is now my pleasure to pass the call over to Rob. 00:01:15.909 -- 00:01:17.504 Please go ahead. 00:01:17.504 -- 00:01:20.729 Thank you, Eugenia, and thank you for joining us today. 00:01:20.729 -- 00:01:26.018 The agenda is a...